The p13II protein of HTLV type 1:: Comparison with mitochondrial proteins coded by other human viruses

被引:19
作者
D'Agostino, DM
Zotti, L
Ferro, T
Franchini, G
Chieco-Bianchi, L
Ciminale, V
机构
[1] Univ Padua, Oncol Sect, Dept Oncol & Surg Sci, I-35128 Padua, Italy
[2] NCI, Basic Res Labs, Div Basic Sci, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1089/08892220050193281
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In addition to the essential regulatory proteins Rex and Tax, the HTLV-1 genome encodes several accessory proteins of yet undefined function, One of these "orphan" proteins, named p13(II), was recently shown to be selectively targeted to mitochondria and to induce specific changes in mitochondrial morphology suggestive of altered inner membrane permeability and swelling. This represented the first report of a retroviral gene product targeted to mitochondria, and suggested that p13(II)-induced alterations in the function of this organelle may play a role in HTLV-1 replication and/or pathogenesis, The more recent findings that both Vpr and Tat of HIV-1 are targeted to mitochondria reinforces the proposed relevance of mitochondrial metabolism to the life cycle of retroviruses, Thus, p13(II), Vpr, and Tat can be added to the growing list of mitochondrial proteins produced by clinically important human viruses, including Epstein-Barr virus, human cytomegalovirus, and hepatitis B virus, Mitochondria are known to play a critical role by providing an amplification loop required for the execution of signaling pathways leading to programmed cell death, The functional consequences of the interactions between viral proteins and mitochondria described so far have been attributed to either the positive or negative? control of apoptotic responses mediated by this organelle, Further analysis of the effects of p13(II) on mitochondrial function is likely to add to our understanding of the mechanisms underlying the development of HTLV-1-associated diseases.
引用
收藏
页码:1765 / 1770
页数:6
相关论文
共 43 条
[1]   Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction [J].
Albrecht, B ;
Collins, ND ;
Newbound, GC ;
Ratner, L ;
Lairmore, MD .
JOURNAL OF VIROLOGICAL METHODS, 1998, 75 (02) :123-140
[2]   IDENTIFICATION OF ALTERNATIVELY SPLICED MESSENGER-RNAS ENCODING POTENTIAL NEW REGULATORY PROTEINS IN CATTLE INFECTED WITH BOVINE LEUKEMIA-VIRUS [J].
ALEXANDERSEN, S ;
CARPENTER, S ;
CHRISTENSEN, J ;
STORGAARD, T ;
VIUFF, B ;
WANNEMUEHLER, Y ;
BELOUSOV, J ;
ROTH, JA .
JOURNAL OF VIROLOGY, 1993, 67 (01) :39-52
[3]   Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo [J].
Bartoe, JT ;
Albrecht, B ;
Collins, ND ;
Robek, MD ;
Ratner, L ;
Green, PL ;
Lairmore, MD .
JOURNAL OF VIROLOGY, 2000, 74 (03) :1094-1100
[4]   Mitochondrial transport of cations: Channels, exchangers, and permeability transition [J].
Bernardi, P .
PHYSIOLOGICAL REVIEWS, 1999, 79 (04) :1127-1155
[5]   EXPRESSION OF ALTERNATIVELY SPLICED HUMAN T-LYMPHOTROPIC VIRUS TYPE-I PX MESSENGER-RNA IN INFECTED CELL-LINES AND IN PRIMARY UNCULTURED CELLS FROM PATIENTS WITH ADULT T-CELL LEUKEMIA LYMPHOMA AND HEALTHY CARRIERS [J].
BERNEMAN, ZN ;
GARTENHAUS, RB ;
REITZ, MS ;
BLATTNER, WA ;
MANNS, A ;
HANCHARD, B ;
IKEHARA, O ;
GALLO, RC ;
KLOTMAN, ME .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :3005-3009
[6]  
Bukrinsky M, 1999, REV MED VIROL, V9, P39, DOI 10.1002/(SICI)1099-1654(199901/03)9:1<39::AID-RMV235>3.0.CO
[7]  
2-3
[8]  
Carbonari M, 1997, BLOOD, V90, P209
[9]   Differential expression of alternatively spliced pX mRNAs in HTLV-I-infected cell lines [J].
Cereseto, A ;
Berneman, Z ;
Koralnik, I ;
Vaughn, J ;
Franchini, G ;
Klotman, ME .
LEUKEMIA, 1997, 11 (06) :866-870
[10]   Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I) [J].
Ciminale, V ;
Zotti, L ;
D'Agostino, DM ;
Ferro, T ;
Casareto, L ;
Franchini, G ;
Bernardi, P ;
Chieco-Bianchi, L .
ONCOGENE, 1999, 18 (31) :4505-4514